These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16407509)

  • 1. A randomized trial of inhaled cyclosporine in lung-transplant recipients.
    Iacono AT; Johnson BA; Grgurich WF; Youssef JG; Corcoran TE; Seiler DA; Dauber JH; Smaldone GC; Zeevi A; Yousem SA; Fung JJ; Burckart GJ; McCurry KR; Griffith BP
    N Engl J Med; 2006 Jan; 354(2):141-50. PubMed ID: 16407509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation blockade with belatacept in renal transplantation.
    Vincenti F; Larsen C; Durrbach A; Wekerle T; Nashan B; Blancho G; Lang P; Grinyo J; Halloran PF; Solez K; Hagerty D; Levy E; Zhou W; Natarajan K; Charpentier B;
    N Engl J Med; 2005 Aug; 353(8):770-81. PubMed ID: 16120857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
    Beniaminovitz A; Itescu S; Lietz K; Donovan M; Burke EM; Groff BD; Edwards N; Mancini DM
    N Engl J Med; 2000 Mar; 342(9):613-9. PubMed ID: 10699160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection.
    Barnes D; Talenti D; Cammell G; Goormastic M; Farquhar L; Henderson M; Vogt D; Mayes J; Westveer MK; Carey W
    Hepatology; 1997 Oct; 26(4):853-7. PubMed ID: 9328304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.
    Vincenti F; Kirkman R; Light S; Bumgardner G; Pescovitz M; Halloran P; Neylan J; Wilkinson A; Ekberg H; Gaston R; Backman L; Burdick J
    N Engl J Med; 1998 Jan; 338(3):161-5. PubMed ID: 9428817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
    Fan Y; Xiao YB; Weng YG
    Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
    Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR
    CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
    Keenan RJ; Konishi H; Kawai A; Paradis IL; Nunley DR; Iacono AT; Hardesty RL; Weyant RJ; Griffith BP
    Ann Thorac Surg; 1995 Sep; 60(3):580-4; discussion 584-5. PubMed ID: 7545889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO; Dias MF; Pacheco-Silva A
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation.
    Keogh A; Spratt P; McCosker C; Macdonald P; Mundy J; Kaan A
    N Engl J Med; 1995 Sep; 333(10):628-33. PubMed ID: 7637723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daclizumab to prevent rejection after cardiac transplantation.
    Hershberger RE; Starling RC; Eisen HJ; Bergh CH; Kormos RL; Love RB; Van Bakel A; Gordon RD; Popat R; Cockey L; Mamelok RD
    N Engl J Med; 2005 Jun; 352(26):2705-13. PubMed ID: 15987919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
    Javadi MA; Feizi S; Karbasian A; Rastegarpour A
    Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled cyclosporine and pulmonary function in lung transplant recipients.
    Groves S; Galazka M; Johnson B; Corcoran T; Verceles A; Britt E; Todd N; Griffith B; Smaldone GC; Iacono A
    J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):31-9. PubMed ID: 19580368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related reversal of acute lung rejection by aerosolized cyclosporine.
    Iacono AT; Smaldone GC; Keenan RJ; Diot P; Dauber JH; Zeevi A; Burckart GJ; Griffith BP
    Am J Respir Crit Care Med; 1997 May; 155(5):1690-8. PubMed ID: 9154878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.